Towia Libermann
9Patents
2h-index
15Co-inventors
48Inventor score
Filing activity: Jul 11, 1994 → Nov 15, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5958403A | Methods and compounds for prevention of graft rejection | Human Necessities | 37 | Expired |
| US5721113A | NERF genes | Chemistry; Metallurgy | 3 | Expired |
| US10604809B2 | Methods and kits for the diagnosis and treatment of pancreatic cancer | Chemistry; Metallurgy | 0 | Active |
| US12372530B2 | Markers for the diagnosis and treatment of non-alcoholic steatohepatitis (NASH) and advanced liver fibrosis | Physics | 0 | Active |
| US8741557B2 | Predicting graft rejection | Emerging Cross-Sectional Technologies | 0 | Active |
| US6960444B2 | Transcriptional mediators of blood vessel development and endothelial differentiation | Human Necessities | 0 | Expired |
| US10884001B2 | Diagnosis of chronic liver diseases | Physics | 0 | Active |
| US6869929B2 | Use of transcription factors for treating inflammation and other diseases | Physics | 0 | Expired |
| US11795213B2 | Methods and compositions for treating celiac disease | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.